Surgeons at NYU Langone’s Heart Valve Center are among the most experienced and sought-out in the country for the treatment of people with heart valve disease.
We are leaders and innovators in the care of people with aortic valve disease, mitral valve disease, and tricuspid valve disease, using transcatheter, robotic, and traditional surgical techniques. Our surgeons were the first in the country to perform several procedures, from a port access mitral valve repair to nonsurgical mitral valve replacement.
We are pioneers in transcatheter approaches for the treatment of heart valve disease that result in quicker, easier recoveries for our patients. During a nonsurgical transcatheter procedure, doctors use a blood vessel in the groin to advance a catheter into your heart. The catheter insertion site in the leg generally needs no more than a Band-Aid, and this short procedure typically allows patients to return home the next day.
To continue the advancement of heart valve technologies and procedures, we are actively involved in research and are currently participating in more than a dozen clinical trials.
Our surgeons have performed more than 3,000 transcatheter aortic valve replacements, among the most in the country. We were the first in the world to perform an advanced type of transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) using the new Medtronic CoreValve™ Evolut™ R Pro System.
“I went in for the TAVR procedure, and I went home the next day. A week later, I had no restrictions on my activity.”
–Thomas, 73; Read All Heart Valve Disease Patient Stories
Our outcomes are among the best in the country. Most patients who have had TAVR recover quickly enough to only require a one-day hospital stay, compared with a nationwide average of three days. Our patients return home twice as quickly as others treated in the region. The survival rate of our patients after TAVR is 99 percent, and our patients have fewer complications than the national average, including a 6-times-lower risk of stroke.
Our cardiac surgeons have performed more than 5,000 mitral valve repair procedures—among the most in the country. We offer a non-surgical percutaneous, or through the skin, mitral valve repair with MitraClip®. During this procedure, a small clip is threaded through a catheter that has been inserted in the femoral vein in the leg. Doctors place the clip on the mitral valve to stop it from leaking.
Our doctors perform more MitraClip® procedures than any other center in the northeast. Nearly all of our patients—97 percent—experience a reduction in mitral regurgitation after the procedure, which leads to a better quality of life. Our risk of complications is four times less than the national average, without any mortality related to the procedure.
We also offer transcatheter mitral valve replacement (TMVR) and were the first to use the LivaNova Caisson TMVR valve for this procedure.
Our team of doctors specializes in evaluating and treating patients with heart valve disease and has pioneered new treatment options that advance patient care.Meet Our Doctors
Mathew R. Williams,
Aubrey C. Galloway,
Didier F. Loulmet,
Cezar S. Staniloae,
Dr. Williams was the first physician in the country to be cross-trained in both cardiac surgery and interventional cardiology. He is a highly skilled valvular disease specialist and has performed more than 4,000 transcatheter valve procedures, more than any other surgeon in the nation. His work in the PARTNER I study played a pivotal role in gaining approval from the U.S. Food and Drug Administration (FDA) for the device and the procedure. Before joining NYU Langone, Dr. Williams served as co-director of the Heart Valve Center at NewYork-Presbyterian/Columbia University, where he established himself as an outstanding young leader in his field. He has published more than 150 scientific papers and serves on numerous national committees. He also has several research grants from the National Institutes of Health.View Full Profile
Dr. Galloway is the Seymour Cohn Professor and Chairman of the Department of Cardiothoracic Surgery at NYU Langone, where he has been on the faculty since 1985. He is internationally recognized for his contributions to mitral valve repair for degenerative disease, surgical treatments for ischemic mitral valve insufficiency, and minimally invasive valve repair and replacement techniques. Dr. Galloway’s work has been a part of national benchmarks for mitral valve reconstruction and minimally invasive cardiac surgery outcomes. He has also been an investigator on numerous clinical trials, has invented and developed many new medical devices related to valve repair and replacement, and has published more than 230 manuscripts in prestigious, peer-reviewed journals.View Full Profile
Dr. Loulmet is a pioneer in robotic cardiac surgery, having performed the world’s first robotic mitral valve repair with Dr. Alain Carpentier in Paris in May 1998 and the world’s first closed chest robotic coronary artery bypass grafting in June 1998. His robotic surgical practice focuses on closed chest mitral valve repair, coronary bypass, and cardiac tumor removal. Dr. Loulmet has performed thousands of mitral valve repair procedures in his career, using the conventional approach, the less invasive technique, and robotic surgery.View Full Profile